Amazon-backed eVTOL company Beta Technologies closes up nearly 6% in NYSE debut

Amazon-backed eVTOL company Beta Technologies closes up nearly 6% in NYSE debut


Kyle Clark, Founder & CEO of Beta Technologies rings the Opening Bell at the New York Stock Exchange on Nov. 4, 2025.

NYSE

Beta Technologies, an electric aircraft company, closed up nearly 6% at $36 a share in its New York Stock Exchange debut on Tuesday.

On Monday, the company priced shares in its IPO at $34 each, above its expected range of $27 to $33. Beta said it sold 29.9 million shares, raising over $1 billion in a deal valuing the company at about $7.4 billion.

Beta’s IPO marks a major test for the small but competitive electric vertical takeoff and landing (eVTOL) industry that’s been vying for approval from the Federal Aviation Administration. The nascent market is currently led by the likes of Joby Aviation and Archer Aviation, and proponents say the technology can ease air traffic congestion.

In Beta’s IPO prospectus, the company names Archer as one of its customers for its ground support equipment, which mostly consists of chargers. Beta says its chargers are installed in 51 U.S. locations.

However, the business is currently very small. During the first half of the year, Beta said its net loss widened to $183.2 million from from $137.1 million in the year-ago period. Revenue more than doubled to $15.6 million from $7.6 million a year ago. Beta was founded in 2017.

Founder and CEO Kyle Clark, who is also a test pilot for Beta, told CNBC on Tuesday that aircrafts are currently conducting certain “back end” missions for the U.S. military. He said he expects the company to achieve full FAA certification for commercial operations in about 30 months

Clark said the company needed to demonstrate success in production and operations and a pipeline of back orders to offer “fundamental business reasons to walk into the public markets.”

Beta is going public during a prolonged government shutdown that started at the beginning of October. The Securities and Exchange Commission is operating with a limited staff.

Still, Clark said the company decided to “keep the train on the rails” and proceed during the shutdown.

Amazon and General Electric are two of the company’s leading investors, with stakes of 10.2% and 6.3%, respectively, before the IPO. GE Aerospace said in September it was making a $300 million in Beta. Amazon first invested in 2021 out of its Climate Pledge Fund, part of an effort to “reach net-zero carbon by 2040.”

Shares of eVTOL competitor Joby and Archer fell 9% and 6%, respectively. Both companies have roughly tripled in value over the last year.

WATCH: Beta Technologies CEO on the company’s market debut

Beta Technologies CEO: Here's how our aircrafts differentiate from competitors



Source

Chinese EV maker Xpeng to launch robotaxis, humanoid robots with self-developed AI chips
World

Chinese EV maker Xpeng to launch robotaxis, humanoid robots with self-developed AI chips

Chinese EV company Xpeng showed off its newest humanoid robot in Guangzhou on Nov. 5, 2025. CNBC | Evelyn Cheng Guangzhou, CHINA — Chinese electric car company Xpeng plans to launch robotaxis next year after previously claiming it wouldn’t be a real business in the near future and took the wraps off of its latest […]

Read More
Asia’s private equity funds turn bullish on China, betting on Beijing’s tech-focused economic plan
World

Asia’s private equity funds turn bullish on China, betting on Beijing’s tech-focused economic plan

Zhang Lei, founder and chairman of Hillhouse Investment, during the Global Financial Leaders’ Investment Summit in Hong Kong, China, on Wednesday, Nov. 5, 2025. Bloomberg | Getty Images Asia-focused private equity managers are turning more bullish on the world’s second-largest economy, betting on Beijing’s drive for technological self-sufficiency and rapid adoption to deliver the next […]

Read More
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
World

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

A box of Ozempic sits on a table in North Tyneside, Britain, Oct. 31, 2023. Lee Smith | Reuters Danish pharmaceutical giant Novo Nordisk said Wednesday it is trimming its growth expectations for its leading obesity and diabetes treatments as competition intensifies and pricing pressures mount in the weight loss market. Net profit for the […]

Read More